Ge Li melds WuXi VC with Frontline, creating an $800M trans-Pacific powerhouse fund now hunting fresh biotech capital
WuXi’s Ge Li is leveraging up a whole new biotech venture group with ambitious plans to add to the hundreds of millions of dollars it’s invested in global biotechs.
Ge Li is throwing in his portfolio of 40 biotechs at WuXi Healthcare Ventures with Frontline BioVentures’ 20 investments, accounting for some $800 million of managed assets. Their new group is being renamed 6 Dimensions Capital and Frontline chief Leon Chen — a veteran Fidelity hand — will take over as CEO with Ge Li standing in as chairman.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.